Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2010
03/31/2010CN101684472A Recombinant fusion proteins containing p53 genes, recombinant and application thereof
03/31/2010CN101684159A Protein derivatives of human granzyme B, and use thereof in targeted therapy on adenocarcinoma
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684151A Protein matter with coagulation activity
03/31/2010CN101684148A Novel surface protein of neisseria meningitidis
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101683533A Gene transfer-mediated angiogenesis therapy
03/31/2010CN101683528A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683522A Novel albumin-free factor viii formulations
03/31/2010CN101683521A Human eryth ropoietin liposome
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/31/2010CN101683519A Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof
03/31/2010CN101683518A Application of FHL 1 in preparing medicament for treating tumour
03/31/2010CN101683416A Natural composition for prevention and control of cardiovascular and cerebrovascular diseases, preparation method and uses thereof
03/31/2010CN101683357A Astragalus polyose solution for aquatic animals and preparation method thereof
03/31/2010CN101683323A Colonic targeted micropill containing vancomycin and preparation method thereof
03/31/2010CN101683317A 缓释组合物 Sustained release composition
03/30/2010US7687614 Monomeric and dimeric fluorescent protein variants and methods for making same
03/30/2010US7687609 Galectin-glycosaminoglycan complex and method for controlling galectin activity
03/30/2010US7687604 Method for purifying marine collagen and the processing thereof into porous sponges
03/30/2010US7687603 Guanidinium delivery carriers
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687489 Agent for treatment of cerebral ischemic diseases
03/30/2010US7687485 Formulation for menopausal women
03/30/2010US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery
03/30/2010US7687467 for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability
03/30/2010US7687466 Abuse-resistant amphetamine prodrugs
03/30/2010US7687465 autoimmune disorders; human leukocyte antigen
03/30/2010US7687464 fusion proteins; membrane proteins; cancer, metastasis
03/30/2010US7687463 Treatment of amyotrophic lateral sclerosis
03/30/2010US7687462 gene therapy; neural epidermal growth factor-like 1(NELL)
03/30/2010US7687461 including PEGylated TNF (tumor necrosis factor) variants; use treating disorders such as diabetes, rheumatoid arthritis and lupus
03/30/2010US7687460 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/30/2010US7687459 serine protease inhibitors; interferons
03/30/2010US7687458 Pharmaceutical compositions of hydrophobic compounds
03/30/2010US7687457 Cyclic molecular framework and derivatives thereof
03/30/2010US7687456 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents
03/30/2010US7687455 comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy
03/30/2010US7687454 Effectors of innate immunity determination
03/30/2010US7687453 Method for administering insulin to the buccal region
03/30/2010US7687266 Pluripotency determining factors and uses thereof
03/30/2010US7687230 Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue
03/30/2010US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof
03/30/2010US7687069 Lytic enzyme produced by bacteria being infected with a bacteriophage specific for such bacteria, useful for treating eye infection
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010US7687058 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
03/30/2010US7687056 containing granulocyte colony-stimulating factor; diabetic nephropathy
03/30/2010CA2527572C Formulations containing thrombolytic agents for rectal administration
03/30/2010CA2484177C Biodegradable, anionic polymers derived from the amino acid l-tyrosine
03/30/2010CA2472237C Multi-stage oral drug controlled-release system
03/30/2010CA2428642C Methods for large scale production of recombinant dna-derived tpa or k2s molecules
03/30/2010CA2380451C Primary composition containing a lipophilic bioactive compound
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2263765C Methods for the production of protein particles useful for delivery of pharmacological agents
03/30/2010CA2260148C Remedies for eating disorders
03/30/2010CA2229479C Method of promoting angiogenesis
03/30/2010CA2208780C Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747
03/30/2010CA2171207C Methods for regulating gastrointestinal motility
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/30/2010CA2144223C Effector proteins of rapamycin
03/25/2010WO2010034032A2 Methods for preparing purified polypeptide compositions
03/25/2010WO2010034031A1 Peptidomimetic macrocycles
03/25/2010WO2010034029A1 Peptidomimetic macrocycles
03/25/2010WO2010034026A1 Peptidomimetic macrocycles
03/25/2010WO2010034015A2 Modulating the alternative complement pathway
03/25/2010WO2010033912A2 Methods, systems, and compositions for calpain inhibition
03/25/2010WO2010033879A2 Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices
03/25/2010WO2010033862A2 Methods for treating cancer
03/25/2010WO2010033854A2 Avian derived fusion proteins
03/25/2010WO2010033771A2 Modulators of hsp70/dnak function and methods of use thereof
03/25/2010WO2010033762A1 Colivelin as a neuroprotective factor
03/25/2010WO2010033688A2 Nucleic acids encoding spider glue proteins and methods of use thereof
03/25/2010WO2010033658A2 Cathepsin l proteolytically processes histone h3 during mouse embroyonic stem cell differentiation
03/25/2010WO2010033294A1 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
03/25/2010WO2010033292A2 Method for medical treatment utilizing l-glutathione
03/25/2010WO2010033275A2 Orally administerable vaccine for yersinia pestis
03/25/2010WO2010033254A1 Process for the synthesis of (aib8,35)hglp-1(7-36)-nh2
03/25/2010WO2010033249A2 Compositions of and methods using ligand dimers
03/25/2010WO2010033187A1 Deep immersion flotation therapy for burn victims
03/25/2010WO2010032322A1 Antiinflammatory peptide
03/25/2010WO2010032140A2 Pharmaceutical compositions and related methods of delivery
03/25/2010WO2010032011A2 Anti-fungal therapy
03/25/2010WO2010032007A1 Use of ctgf as a cardioprotectant
03/25/2010WO2010031859A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
03/25/2010WO2010031829A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside
03/25/2010WO2010031828A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
03/25/2010WO2010031801A2 Composition and methods for modulating toll-like receptor activity
03/25/2010WO2010031744A1 Whey and thymus function
03/25/2010WO2010031577A1 Use of bradykinin b1 receptor antagonists in intestinal fibrosis treatment
03/25/2010WO2010031361A1 A composition with inhibition activity on pathological angiogenesis
03/25/2010WO2010031262A1 A glycoprotein composition almost containing no subunit and preparation method thereof
03/25/2010WO2010031171A1 Iap bir domain binding compounds
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010012640A3 Particles of collagen material and process for the preparation
03/25/2010WO2010012088A8 Soluble igf receptors as anti-angiogenic agents
03/25/2010WO2010007515A3 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
1 ... 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 ... 3163